H. George Conrades's Insider Trades & SAST Disclosures
H. George Conrades's most recent trade in Oracle Corp. was a trade of 22,500 Stock Option done . Disclosure was reported to the exchange on April 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern H. George Conrades.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2025 | 22,500 | 0 | - | - | Stock Option | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.49 per share. | 21 Apr 2025 | 22,500 | 43,639 (0%) | 0% | 43.5 | 978,525 | Common Stock |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 3,303 | 21,139 (0%) | 0% | - | Common Stock | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 3,303 | 0 | - | - | Restricted Stock Unit | |
| Oracle Corp. | George H. Conrades | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 2,986 | 2,986 | - | - | Restricted Stock Unit | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 20,000 | 0 | - | - | Stock Option | |
| Oracle Corp. | George H. Conrades | Director | Sale of securities on an exchange or to another person at price $ 116.00 per share. | 03 May 2024 | 20,000 | 17,836 (0%) | 0% | 116 | 2,320,000 | Common Stock |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.02 per share. | 03 May 2024 | 20,000 | 37,836 (0%) | 0% | 42.0 | 840,400 | Common Stock |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.02 per share. | 01 May 2024 | 25,000 | 42,836 (0%) | 0% | 42.0 | 1,050,500 | Common Stock |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 25,000 | 20,000 | - | - | Stock Option | |
| Oracle Corp. | George H. Conrades | Director | Sale of securities on an exchange or to another person at price $ 116.13 per share. | 01 May 2024 | 25,000 | 17,836 (0%) | 0% | 116.1 | 2,903,190 | Common Stock |
| Oracle Corp. | H. Conrades George | Director | Sale of securities on an exchange or to another person at price $ 113.76 per share. | 10 Nov 2023 | 2,325 | 17,836 (0%) | 0% | 113.8 | 264,494 | Common Stock |
| Oracle Corp. | H. George Conrades | Director | Sale of securities on an exchange or to another person at price $ 111.97 per share. | 10 Nov 2023 | 2,325 | 20,161 (0%) | 0% | 112.0 | 260,334 | Common Stock |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 4,866 | 22,486 (0%) | 0% | - | Common Stock | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 4,866 | 0 | - | - | Restricted Stock Unit | |
| Oracle Corp. | George H. Conrades | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 3,303 | 3,303 | - | - | Restricted Stock Unit | |
| Oracle Corp. | George H. Conrades | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Dec 2022 | 37,500 | 17,620 (0%) | 0% | 0 | Common Stock | |
| Cyclerion Therapeutics Inc | George H. Conrades | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Oracle Corp. | George H. Conrades | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 4,866 | 4,866 | - | - | Restricted Stock Unit | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 4,445 | 0 | - | - | Restricted Stock Unit | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 4,445 | 55,120 (0%) | 0% | - | Common Stock | |
| Cyclerion Therapeutics Inc | George H. Conrades | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2021 | 6,509 | 50,675 (0%) | 0% | - | Common Stock | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2021 | 6,509 | 0 | - | - | Restricted Stock Unit | |
| Oracle Corp. | George H. Conrades | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2021 | 4,445 | 4,445 | - | - | Restricted Stock Unit | |
| Cyclerion Therapeutics Inc | George H. Conrades | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2020 | 11,857 | 44,166 (0%) | 0% | - | Common Stock | |
| Oracle Corp. | George H. Conrades | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2020 | 11,857 | 0 | - | - | Restricted Stock Unit | |
| Oracle Corp. | George H. Conrades | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2020 | 6,509 | 6,509 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges